Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

At the frontiers of lung fibrosis therapy

Despite recent failures, a flurry of activity in biotech and pharma is raising hopes that an effective drug for this fatal lung disease is on the way. Ken Garber investigates.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: In IPF, the normal wound healing response goes fatally wrong, as resident fibroblasts become collagen-secreting myofibroblasts that cause continuous scar formation in the lung.

Katie Vicari


  1. Noble, P.W. et al. Lancet 377, 1760–1769 (2011).

    Article  CAS  Google Scholar 

  2. Raghu, G. et al. Am. J. Respir. Crit. Care Med. 183, 788–824 (2011).

    Article  Google Scholar 

  3. Barry-Hamilton, V. et al. Nat. Med. 16, 1009–1017 (2010).

    Article  CAS  Google Scholar 

  4. Tager, A.M. et al. Nat. Med. 14, 45–54 (2008).

    Article  CAS  Google Scholar 

  5. Richeldi, L. et al. N. Engl. J. Med. 365, 1079–1087 (2011).

    Article  CAS  Google Scholar 

  6. Maher, T.M. Eur. Respir. Rev. 22, 148–152 (2013).

    Article  Google Scholar 

  7. Idiopathic Pulmonary Fibrosis Clinical Research Network. N. Engl. J. Med. 366, 1968–1977 (2012).

  8. Van Den Blink, B. et al. American Thoracic Society meeting abstract A5707 (2013).

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

At the frontiers of lung fibrosis therapy. Nat Biotechnol 31, 781–783 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing